title: Will they deliver treatment access?: WTO rules and Canada's law on generic medicine exports.
abstract: More than two years since Canada enacted the Jean Chrétien Pledge to Africa, no generic medication produced under compulsory license has yet been exported from Canada. In this feature article, Richard Elliott describes attempts by two Canadian generic pharmaceutical companies to navigate the complicated and unwieldy processes established under the Act, and, noting the government's pledge to review the law and fix it to make it work, prescribes a number of ways in which the process should be streamlined.
authors: Richard
authors: R
authors: Elliott
mesh_terms: D019380:Anti-HIV Agents / Q000600:supply & distribution*; D000998:Antiviral Agents / Q000600:supply & distribution*; D002170:Canada; D003132:Commerce / Q000331:legislation & jurisprudence*; D004345:Drug Industry / Q000458:organization & administration*; D016568:Drugs, Generic / Q000600:supply & distribution*; D006297:Health Services Accessibility; D006801:Humans; D007251:Influenza, Human / Q000188:drug therapy / Q000453:epidemiology
chemical_list: D019380:Anti-HIV Agents; D000998:Antiviral Agents; D016568:Drugs, Generic